Tanja V. Kral

Other : As defined under Penn's governing FCOI Policy, Dr. Kral has the following SFI – “Clinical Trial Intellectual Property,” an interest in intellectual property that is the subject of a copyright, issued patent, or a patent application (regardless of whether the intellectual property has been patented, licensed, or assigned to the University) if such intellectual property is being tested, evaluated, or developed in, or if its commercial value could be affected by, a clinical trial in which the Investigator is engaged or proposes to engage. She has not received any royalties.

Mobile health (mHealth) nutrition intervention for children with Autism Spectrum Disorder

Public Health Relevance: The high prevalence of mealtime difficulties and obesity among children with autism spectrum disorder (ASD) calls for new and innovative ways to promote healthy eating and weight development in this population. The proposed project aims to develop and test, for the first time, an interactive mobile health (mHealth) nutrition intervention, which incorporates core behavior change strategies that have been empirically tested in family-based nutrition research and behavioral interventions with children with ASD. The feasibility and efficacy of this mHealth intervention to improve dietary outcomes in children with ASD will be tested in a proof-of-concept randomized controlled trial.